Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LingZhi capsule
DRUG
2 trials
Sponsors
Chinese University of Hong Kong
, The University of Hong Kong
Conditions
Chronic Fatigue Syndrome (CFS)
Pediatric Cancers
Post-COVID ME/CFS
Phase 2
RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue
Not yet recruiting
NCT06739720
The University of Hong Kong
Chronic Fatigue Syndrome (CFS), Post-COVID ME/CFS
Start: 2025-01-02
End: 2026-12-31
Target: 130
Updated: 2024-12-18
Phase 3
Lingzhi for Cancer Children
Completed
NCT00575926
Chinese University of Hong Kong
Pediatric Cancers
Start: 2002-09-30
End: 2007-09-30
Updated: 2007-12-18
Related Papers
Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post-COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial.
2026-01-20
Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial (Preprint)
2025-08-19